Unknown

Dataset Information

0

Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.


ABSTRACT: Chronic kidney disease is characterized by interstitial fibrosis and proliferation of scar-secreting myofibroblasts, ultimately leading to end-stage renal disease. The hedgehog (Hh) pathway transcriptional effectors GLI1 and GLI2 are expressed in myofibroblast progenitors; however, the role of these effectors during fibrogenesis is poorly understood. Here, we demonstrated that GLI2, but not GLI1, drives myofibroblast cell-cycle progression in cultured mesenchymal stem cell-like progenitors. In animals exposed to unilateral ureteral obstruction, Hh pathway suppression by expression of the GLI3 repressor in GLI1+ myofibroblast progenitors limited kidney fibrosis. Myofibroblast-specific deletion of Gli2, but not Gli1, also limited kidney fibrosis, and induction of myofibroblast-specific cell-cycle arrest mediated this inhibition. Pharmacologic targeting of this pathway with darinaparsin, an arsenical in clinical trials, reduced fibrosis through reduction of GLI2 protein levels and subsequent cell-cycle arrest in myofibroblasts. GLI2 overexpression rescued the cell-cycle effect of darinaparsin in vitro. While darinaparsin ameliorated fibrosis in WT and Gli1-KO mice, it was not effective in conditional Gli2-KO mice, supporting GLI2 as a direct darinaparsin target. The GLI inhibitor GANT61 also reduced fibrosis in mice. Finally, GLI1 and GLI2 were upregulated in the kidneys of patients with high-grade fibrosis. Together, these data indicate that GLI inhibition has potential as a therapeutic strategy to limit myofibroblast proliferation in kidney fibrosis.

SUBMITTER: Kramann R 

PROVIDER: S-EPMC4563736 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.

Kramann Rafael R   Fleig Susanne V SV   Schneider Rebekka K RK   Fabian Steven L SL   DiRocco Derek P DP   Maarouf Omar O   Wongboonsin Janewit J   Ikeda Yoichiro Y   Heckl Dirk D   Chang Steven L SL   Rennke Helmut G HG   Waikar Sushrut S SS   Humphreys Benjamin D BD  

The Journal of clinical investigation 20150720 8


Chronic kidney disease is characterized by interstitial fibrosis and proliferation of scar-secreting myofibroblasts, ultimately leading to end-stage renal disease. The hedgehog (Hh) pathway transcriptional effectors GLI1 and GLI2 are expressed in myofibroblast progenitors; however, the role of these effectors during fibrogenesis is poorly understood. Here, we demonstrated that GLI2, but not GLI1, drives myofibroblast cell-cycle progression in cultured mesenchymal stem cell-like progenitors. In a  ...[more]

Similar Datasets

| S-EPMC3338902 | biostudies-literature
| S-EPMC9245900 | biostudies-literature
2023-05-17 | GSE232435 | GEO
| S-EPMC10443806 | biostudies-literature
| S-EPMC7611626 | biostudies-literature
| S-EPMC3336787 | biostudies-literature
| S-EPMC6948871 | biostudies-literature
| S-EPMC7554244 | biostudies-literature
| S-EPMC2833233 | biostudies-literature
| S-EPMC5719458 | biostudies-literature